SignatureFD’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22
| Closed | -$234 | – | 3442 |
|
|
2024
Q4 | $234 | Sell |
22
-358
| -94% | -$3.81K | ﹤0.01% | 3208 |
|
|
2024
Q3 | $4.83K | Sell |
380
-117
| -24% | -$1.49K | ﹤0.01% | 2577 |
|
|
2024
Q2 | $8.34K | Sell |
497
-153
| -24% | -$2.57K | ﹤0.01% | 2345 |
|
|
2024
Q1 | $9.75K | Buy |
650
+34
| +6% | +$510 | ﹤0.01% | 2311 |
|
|
2023
Q4 | $9.24K | Buy |
616
+536
| +670% | +$8.04K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $1.12K | Buy |
+80
| New | +$1.12K | ﹤0.01% | 2907 |
|
|
2021
Q4 | – | Sell |
-1,509
| Closed | -$25K | – | 3275 |
|
|
2021
Q3 | $25K | Buy |
1,509
+1,322
| +707% | +$21.9K | ﹤0.01% | 1660 |
|
|
2021
Q2 | $3K | Buy |
187
+59
| +46% | +$947 | ﹤0.01% | 2488 |
|
|
2021
Q1 | $2K | Sell |
128
-25
| -16% | -$391 | ﹤0.01% | 2532 |
|
|
2020
Q4 | $3K | Sell |
153
-13
| -8% | -$255 | ﹤0.01% | 2179 |
|
|
2020
Q3 | $3K | Buy |
166
+119
| +253% | +$2.15K | ﹤0.01% | 2119 |
|
|
2020
Q2 | $1K | Sell |
47
-81
| -63% | -$1.72K | ﹤0.01% | 2387 |
|
|
2020
Q1 | $2K | Sell |
128
-2,872
| -96% | -$44.9K | ﹤0.01% | 2003 |
|
|
2019
Q4 | $100K | Hold |
3,000
| – | – | 0.01% | 711 |
|
|
2019
Q3 | $71K | Buy |
+3,000
| New | +$71K | 0.01% | 795 |
|